| DSI | deep shock insulin; Depression Status Inventory; disulfide isomerase; Down Syndrome International |
|---|---|
| GPI | general paralysis of the insane; glucose phosphate isomerase; glycoprotein I; glycosylphosphatidylin... |
| HIM | hepatitis-infectious mononucleosis; hexosephosphate isomerase |
| MPI | mannose phosphate isomerase; master patient index; maximum permitted intake; maximum point of impuls... |
| PGI | phosphoglucose isomerase; potassium, glucose, and insulin; prostaglandin I |
| nomifensine maleate | 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline maleate;an antidepressant. (05 Mar 2000) |
|---|---|
| dexbrompheniramine maleate | <chemical> D-2-[p-Bromo-alpha-(2-dimethylaminoethyl)benzyl]pyridine maleate;the dextrorotatory isomer of brompheniramine; an antihistamine. (05 Mar 2000) |
| dexchlorpheniramine maleate | <chemical> D-2-[p-Chloro-alpha-(2-dimethylaminoethyl)benzyl]pyridine maleate;the dextrorotatory isomer of chlorpheniramine; an antihistamine. (05 Mar 2000) |
| dimethindene maleate | 2-[1-[2-(2-Dimethylaminoethyl)inden-3-yl]ethyl]pyridine maleate;an antihistamine also used as an antipruritic. (05 Mar 2000) |
| dizocilpine maleate | <chemical> 10,11-dihydro-5-methyl-5h-dibenzo(a,d)cyclohepten-5,10-imine maleate. A potent noncompetitive antagonist of the nmda receptor (receptors, n-methyl-d-aspartate) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which nmda receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects. Pharmacological action: excitatory amino acid antagonists, neuroprotective agents. Chemical name: 5H-Dibenzo(a,d)cyclohepten-5,10-imine, 10,11-dihydro-5-methyl-, (5S)-, (Z)-2-butenedioate (1:1) (12 Dec 1998) |
| thiethylperazine maleate | 2-Ethyl-mercapto-10-3-(1-methyl-4-piperazinyl)propyl phenothiazine dimaleate;an antiemetic agent used to control nausea and vomiting associated with vertigo, the administration of general anaesthetics, and with several other clinical conditions; it also has weak hypotensive, spasmolytic, antihistaminic, and hypothermic actions. (05 Mar 2000) |
| timolol maleate | (-)-1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate;a beta-adrenergic blocking agent used in the treatment of hypertension and used in eyedrops in the treatment of chronic open-angle glaucoma. (05 Mar 2000) |
| enalapril maleate | L-Proline, 1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-,(S)-, (Z)-2-butenedioate (1:1);a prodrug for enalaprilat, an angiotensin-converting enzyme inhibitor used as an anti-hypertensive agent. (05 Mar 2000) |
| ergometrine maleate | ergonovine maleate |
| acetylene-allene thioester isomerase | <enzyme> Converts 3-acetylenic fatty acyl thioesters to 2,3-dienoyl fatty acyl thioesters Registry number: EC 5.3.99.- (26 Jun 1999) |
| arabinose-5-phosphate isomerase | <enzyme> Catalyses reversibly the conversion of arabinose phosphate to ribulosephosphate Registry number: EC 5.3.1.13 Synonym: arabinose 5-phosphate ketolisomerase, arabinosephosphate isomerase (26 Jun 1999) |
| galactose-6-phosphate isomerase | <enzyme> Converts galactose 6-phosphate to tagatose 6-phosphate Registry number: EC 5.3.1.- Synonym: galactose 6-phosphate isomerase, gal-6-p isomerase, tagatose-6-phosphate isomerase (26 Jun 1999) |
| maleylpyruvate isomerase | <enzyme> Catalyses isomerization of 3-maleylpyruvate to 3-fumarylpyruvate Registry number: EC 5.2.1.4 (26 Jun 1999) |
| mannose-6-phosphate isomerase | <enzyme> An enzyme that catalyses the reversible isomerization of d-mannose-6-phosphate to form d-fructose-6-phosphate, an important step in glycolysis. Chemical name: D-Mannose-6-phosphate ketol isomerase Registry number: EC 5.3.1.8 (12 Dec 1998) |
| mannosephosphate isomerase | <enzyme> An enzyme that catalyses the reversible conversion of d-mannose-6-phosphate to d-fructose-6-phosphate; a key step in the synthesis of mannose derivatives as well as the entry of mannose into the central pathways of carbohydrate metabolism. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|